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Pleuritic Chest Pain in a 24-Year-Old Man with Crohn’s Disease
Mohamed M. Rezik1 and Daniel R. Ouellette2
1Department of Internal Medicine and 2Department of Pulmonary and Critical Care Medicine, Henry Ford Health System, Detroit,
Michigan
Figure 1. Multiple computed tomographic scan images of the chest, revealing (A–C) multiple pulmonary
nodules (arrows), including (C) a cavitary nodule (arrow) as well as (D) a pleural effusion (arrow).
A24-year-oldman presentedwith 2weeks
of pleuritic chest pain and 1 day of dyspnea.
He had asymptomatic Crohn’s disease
diagnosed via biopsy 2 years earlier. He
had never received immunosuppressive
therapy. Right flank tenderness was noted
on examination. A chest X-ray suggested a
small right pleural effusion. A computed
tomographic scan additionally revealed
multiple right-sided pulmonary nodules,
the largest measuring 11 mm (Figure 1).
Wedge resection of multiple nodules via
thoracoscopy was performed, revealing
necrotizing granulomas with surrounding
acute and chronic inflammation (Figure 2).
Mycobacterial and fungal staining produced
negative results, and no evidence of sys-
temic vasculitis or other granulomatous
disease was evident. The diagnosis of nec-
robiotic granulomatous pulmonary nodules
secondary to Crohn’s disease was made.
After treatment with prednisone, follow-
up several weeks later revealed complete
resolution of symptoms and of the pleural
effusion (Figure 3).
To our knowledge, this is the sixth
reported case of necrobiotic nodules sec-
ondary to Crohn’s disease (1–5) and the
first to report the presence of a concom-
itant pleural effusion. Three of the six
reported patients, including ours, had inactive bowel disease at the time of diagnosis. All but one patient had respiratory symptoms
leading to diagnosis, whereas the last was found incidentally on imaging.
Extraintestinal manifestations of inflammatory bowel disease (IBD) are found in up to 41% of patients and are generally well
recognized (6). Pulmonary manifestations of IBD, however, are an uncommon form of extraintestinal IBD and are therefore often
overlooked (7). Although the prevalence of pulmonary manifestations is unknown (8), many forms of pulmonary disease have clearly
been identified in association with IBD.
The most commonly associated pulmonary manifestation is airway disease, such as bronchiectasis or bronchitis (9). Up to 50%
of patients with IBD have been found to have abnormalities on pulmonary testing, a rate higher than that of the general population
and suggesting a high rate of subclinical disease (10). Pulmonary nodules in patients with IBD may be necrobiotic (as seen here),
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granulomatous, or inflammatory (11). Also seen are parenchymal diseases such as cryptogenic organizing pneumonia and serositis
causing pleural effusions or pericarditis (8). Patients with IBD also have a higher rate of thromboembolism and are at risk of
developing drug-induced, post-treatment disease such as eosinophilic pneumonia or pulmonary fibrosis (8).
Pulmonary diseases are a rare and largely unrecognized extraintestinal manifestation of IBD. Physicians must be aware of their
existence to ensure the proper diagnosis and management of patients with IBD presenting with respiratory abnormalities. n
Author disclosures are available with the text of this article at www.atsjournals.org.
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Figure 2. Histological images revealing (A, original magnification,34; and B, original magnification,310) necrotizing granulomatous inflammation (arrows)
and (C) giant cells (arrows) (original magnification, 320).
Figure 3. Posteroanterior (PA) and lateral chest X-rays, revealing resolution of the
previously seen right-sided pleural effusion after treatment with prednisone.
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